Sample Submission Guidelines Inquiry
Request a Quote

Lipid Metabolism Pathway Analysis Service

The same palmitate molecule can sit in a stored triacylglycerol, be esterified into a membrane phospholipid, be oxidized for ATP, or be released as a signaling mediator, and a total fatty acid value cannot tell those states apart. We quantify the pools and the pathway steps together by LC-MS/MS — free and esterified fatty acids, glycerolipids, glycerophospholipids, sphingolipids, sterols, bile acids, acylcarnitines, ketone bodies, and oxidized lipid mediators — and return the ratios that show which route has shifted.

Free and esterified fatty acids quantified separately, so a change in the active fraction is not diluted by the storage pool

Positional and geometric isomers resolved, including sn-1 versus sn-2 acyl placement and cis versus trans configuration

Acylcarnitines reported species by species, which separates a mitochondrial import defect from a chain-length-specific oxidation defect

Oxidized lipid mediators extracted under antioxidant protection, so processing artifacts are not read as biological enrichment

Pathway indices delivered with the concentrations: desaturation, elongation, de novo lipogenesis, free-to-esterified, and ketone body ratios

Lipid metabolism analysis — LC-MS/MS quantification across fatty acid, glycerolipid, phospholipid, sterol, and oxidation routes

What Lipid Metabolism Analysis Measures

The panel reports the pools that lipid metabolism moves material between, showing direction of change rather than abundance alone: fatty acids split by esterification state and chain structure, the glycerolipid and phospholipid species that carry them, the sterol and bile acid routes that dispose of them, and the acylcarnitine, ketone, and oxidized mediator readouts downstream. Concentrations, ratios, and the normalization basis arrive together, so a difference can be attributed to a pathway rather than to sample handling.

Six steps carry most of the information. Supply covers exogenous fatty acids and the fraction synthesized from acetyl-CoA. Activation and esterification describe how acyl chains are committed to storage through glycerol-3-phosphate acylation and diacylglycerol acyltransferase, or to membranes through the Kennedy pathway. Storage and mobilization are read from triacylglycerol and diacylglycerol species against the free fatty acid pool. Oxidation is read from mitochondrial import, where long-chain acylcarnitines are the carrier, and from the β-oxidation output. Remodeling is read from lysophospholipid-to-phospholipid ratios and sphingolipid species; disposal from bile acids and oxidized lipid mediators.

Two limits shape how the data should be read. A concentration describes pool size, not the rate at which material moves through it: an oxidation inhibitor can raise long-chain acylcarnitines without changing how much fat the tissue burns. Lipid pools are also compartmentalized, so a tissue homogenate averages lipid droplets against membranes and lipoprotein cargo. Both limits are stated in the report rather than left to be discovered after publication.

The Lipid Pools We Quantify and What Each One Reports

The panel is organized by pathway rather than by compound class, so the analyte list matches the decision the study has to make. Segments are selected at study design; there is no requirement to run all of them, and each is quantified independently to absolute concentration.

Pool or Node Representative Analytes What It Reports
Fatty acyl pool Free fatty acids (FFA) and total fatty acids after hydrolysis, reported as separate values; saturated and monounsaturated species; the n-3 and n-6 families reported through their parent species — alpha-linolenic acid, linoleic acid, and arachidonic acid; products of unsaturated fatty acid biosynthesis, including trans isomers, odd-chain species, and very-long-chain species Supply and mobilization. The free fraction carries the metabolic signal — adipose release, lipotoxicity, ligand availability — while the esterified fraction reports stored and structural material.
Glycerolipid storage pool Triacylglycerol, diacylglycerol, and monoacylglycerol species resolved by acyl chain composition Esterification and storage load, plus the intermediate that accumulates when the last acylation step is rate-limited. The same triacylglycerol mass can be built from different acyl combinations, so species are reported individually rather than as a class sum.
Membrane phospholipid pool Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidic acid, lysophospholipids, plasmalogens, and cardiolipin where required Remodeling and membrane composition, including the phosphatidic acid and diacylglycerol intermediates shared with the storage route. Positional information on the acyl chains is available where the study needs it.
Sphingolipid pool Ceramides by chain length, sphingomyelin, hexosylceramides, sphingosine, and sphingosine-1-phosphate Stress and death signaling that runs in parallel with acyl-chain handling. Because the free and esterified forms behave differently, the ratio of sphingosine-1-phosphate to its precursors is reported rather than each value alone.
Sterol pool Cholesterol, cholesteryl esters, lathosterol, desmosterol, 7-dehydrocholesterol, plant sterols, oxysterols, and — where the study needs them — the steroid hormones derived from cholesterol Whether cholesterol is being synthesized or absorbed, and how much has been converted to oxidized derivatives. Mevalonate pathway intermediates are reported as synthesis precursors rather than as a summary sterol value.
Bile acid pool Primary and secondary species in free and glycine- or taurine-conjugated form, with 12α-hydroxylated and non-12α-hydroxylated species distinguished Hepatic disposal of cholesterol and the microbial contribution to the circulating pool. Conjugation state must be preserved, so species are quantified individually rather than as total bile acids.
Mitochondrial import and oxidation Acylcarnitines reported species by species with free carnitine as the denominator, plus β-hydroxybutyrate and acetoacetate How much acyl chain enters the mitochondrion and whether oxidation completes. The chain-length distribution localizes a defect, which is why the profile is reported as a spectrum rather than a total.
Oxidized lipid mediators Enzymatically derived oxylipins covering cyclooxygenase, lipoxygenase, and cytochrome P450 products, with isoprostanes, malondialdehyde, and 4-hydroxynonenal as non-enzymatic markers Signal output at the boundary between lipid pools and oxidative stress. These analytes require their own extraction and their own aliquot, so that enzymatic and autoxidative products stay distinguishable.

Where a study needs only the free fraction measured against the esterified fraction — the comparison that separates adipocyte mobilization from impaired re-esterification — the same analytes are reported as a free fatty acid panel, with both fractions derived from one extraction. Feasibility, working range, and the achievable limit of quantification are confirmed per matrix before samples are processed.

Key Challenges in Lipid Metabolism Analysis and How We Solve Them

  • Free and Esterified Fatty Acids Reported as One Value — A hydrolyzed total fatty acid value is the simplest number to produce and the wrong one for a metabolism question: the free fraction is a small percentage of the total, so the change that matters for insulin resistance and lipotoxicity barely registers. We quantify both fractions from one extraction with isotope-labeled standards and report the free-to-esterified ratio.
  • Positional and Geometric Isomers Co-Elute — Two lipid species can share a molecular formula, a precursor ion, and a product ion while differing in acyl placement or geometry: phospholipase A2 acts on sn-2, and cis and trans C18:1 have the same mass but are not equivalent dietary markers. Neither pair separates on a single MRM transition, so we resolve them by C30 reversed-phase gradients and gas-phase separation of methyl esters.
  • Oxidized Lipids Form During Processing, Not in the Sample — Oxylipins and oxysterols sit at low nanomolar concentrations and are generated enzymatically in vivo, so oxidation after collection is indistinguishable from biology; polyunsaturated fatty acids generate isoprostane and aldehyde artifacts on exposure to air, light, or repeated thawing. Antioxidant and chelator are assigned per matrix, samples are frozen in single-use aliquots, and non-enzymatic markers are acquired alongside the enzymatic products.
  • Acylcarnitines Lose Their Meaning as a Single Sum — Carnitine carries activated fatty acids across the mitochondrial membrane, and the chain length of the species that accumulates identifies where the pathway is blocked: a block at import produces a long-chain pattern, a defect inside the oxidation spiral leaves partially oxidized species of intermediate length. Summing them into a total acylcarnitine value discards that information. We quantify individual species against free carnitine instead.
  • The Normalization Basis Can Reverse a Conclusion — Lipid values are unusually sensitive to the normalizer because lipid content varies more between samples than most metabolite classes: a result expressed per milligram of wet weight, per milligram of protein, or per total phospholipid can move a comparison in different directions, particularly in liver, adipose, and brain. A lipemic serum sample also dilutes every analyte through lipid volume rather than biology. We measure the normalizer in the same extraction.

Pathway Indices Reported With Every Dataset

Ratio-based readouts carry pathway direction that single concentrations do not, and in most designs they are computed from analytes already being quantified. They are surrogates, not rates: each index reports relative activity of one step under defined conditions, and none substitutes for a labeled tracer study. Every index is computed only from analytes measured in the same batch, and the report names the samples that entered each calculation.

Index Computation What a Shift Indicates
Desaturation Palmitoleic acid divided by palmitic acid, and oleic acid divided by stearic acid Relative stearoyl-CoA desaturase activity, the step that sets membrane fluidity and the substrate pool for esterification. Widely used in liver and adipose models where the enzyme is a therapeutic target.
Elongation Stearic acid divided by palmitic acid Whether elongation keeps pace with synthesis, and whether very-long-chain species are being produced at the expense of C16 chains.
Synthesis versus dietary supply Palmitic acid divided by linoleic acid Relative de novo lipogenesis. Linoleic acid cannot be synthesized and is supplied by diet, so an endogenous palmitate excess dilutes it. Interpretable only when the dietary background is comparable between groups.
Free-to-esterified balance Free fatty acids against the sum of triacylglycerol and cholesteryl ester fatty acids Mobilization against storage. A rise indicates lipolysis exceeding re-esterification or impaired uptake; a fall indicates the opposite. Both fractions are quantified from one extraction.
Saturation balance Saturated species against monounsaturated plus polyunsaturated species Membrane ordering and the balance between elongation and desaturation output; a coarse but robust comparator across large sample sets.
Cholesterol source Lathosterol and desmosterol divided by cholesterol for synthesis; sitosterol and campesterol for absorption Where circulating or tissue cholesterol came from. Synthesis and absorption move independently, so a single cholesterol value cannot answer the question that statin and ezetimibe studies are designed to ask.
Ketone body balance β-hydroxybutyrate divided by acetoacetate Hepatic mitochondrial redox state and the completeness of β-oxidation, read from the two products of the same acetyl-CoA pool rather than from one of them.
Bile acid conjugation Glycine-conjugated against taurine-conjugated species, with the 12α-hydroxylated fraction reported separately Hepatic conjugation capacity and the composition of the pool returned to the gut. The ratio is species-dependent, so all groups being compared have to be the same species.
Acylcarnitine pattern Individual species against free carnitine, with the long-chain fraction and the acetylcarnitine fraction reported separately Mitochondrial import capacity against completed oxidation. A long-chain accumulation with a low acetylcarnitine fraction indicates an import limitation rather than reduced oxidation per se.

Analytical Platform & Method for Lipid Quantification

Platform

  • Chromatographic separation — reversed-phase UHPLC with C18 chemistry, long C30 gradients where isomeric acyl species must be resolved, and hydrophilic interaction separation for acylcarnitines and polar lipid intermediates.
  • Quantification — triple quadrupole mass spectrometry in scheduled MRM, with positive and negative ion mode acquired in one batch so that fatty acids and their esterified forms share a single calibration set.
  • High-resolution confirmation — accurate mass acquisition on an Orbitrap platform for species assignment and for any analyte whose identity depends on more than a transition ratio.
  • Gas-phase separation for fatty acid composition — methyl ester derivatization with gas chromatography for chain-length profiling, cis and trans configuration, and sterols, where volatility-based separation outperforms liquid chromatography.
  • Internal standards — isotope-labeled analogues for each lipid class, including free fatty acids, triacylglycerol, phospholipid, cholesteryl ester, and oxylipins, spiked before extraction so that recovery and matrix effects are corrected per sample.
  • Batch structure — calibration standards and pooled quality control samples interleaved through every batch, with all groups of one comparison acquired together and a defined position in the extraction queue.

Method Performance

Parameter What We Report
Calibration Matrix-matched curves with weighted regression; R² ≥ 0.995 for analytes covered by authentic standards, with back-calculated accuracy at every level and the working range stated per analyte.
Precision Replicate CV ≤ 10% for quantified lipid classes, with pooled quality control dispersion reported per species, including the polyunsaturated species most sensitive to oxidation.
Accuracy Recovery corrected per sample against class-specific isotope-labeled internal standards spiked at the earliest point in processing, reported alongside the uncorrected response.
Sensitivity Analyte-dependent. Free fatty acids, acylcarnitines, and bile acids are typically quantified in the low nanomolar range, while oxidized lipid mediators are measured at picogram levels where sample amount supports it. The limit of quantification is reported per analyte, not as a single assay figure.
Isomer selectivity Resolution of critical pairs demonstrated in spiked matrix for every reported class, including cis and trans C18:1, sn-positional acyl placement where it is claimed, and the ether-linked species that overlap with their diacyl analogues.
Sample-level QC Internal standard response, retention time stability, carryover, and the oxidation marker panel reported for every sample, so individual results can be accepted or flagged rather than averaged into a group value.
Waters ACQUITY UPLC system used for chromatographic separation of lipid classes and acyl species

Waters ACQUITY UPLC System (Figure from Waters)

SCIEX QTRAP 6500+ triple quadrupole for scheduled MRM quantification of fatty acids, glycerolipids, and acylcarnitines

SCIEX QTRAP 6500+ LC-MS/MS System (Figure from SCIEX)

Thermo Q Exactive Orbitrap for accurate mass confirmation of lipid species and oxidized derivatives

Thermo Q Exactive Orbitrap (Figure from Thermo Fisher Scientific)

Agilent 7890B-5977A GC-MS for fatty acid methyl ester profiling and sterol measurement

Agilent 7890B-5977A GC-MS System (Figure from Agilent)

Lipid Metabolism Analysis Workflow

1

Study design and panel selection

Matrices, comparisons, and derived ratios are fixed first, because the index you need determines which analytes must be quantified absolutely and whether an isomer resolution claim has to be demonstrated.

2

Pre-analytical specification

Anticoagulant or collection buffer, antioxidant and chelator where required, light protection, fasting state, hold time, and the single-use aliquot plan are assigned per matrix before the first sample is collected. This step protects the free fatty acid and oxylipin pools, and it cannot be recovered afterwards.

3

Extraction with class-specific internal standards

Isotope-labeled standards for each lipid class go in before homogenization. Free and esterified fractions are separated rather than hydrolyzed together when the free pool is part of the question, oxidized lipid mediators are extracted under antioxidant protection, and the study normalizer is measured from the same extraction.

4

Acquisition

Scheduled MRM for the quantified species, accurate mass acquisition for confirmation, and gas-phase separation for fatty acid composition and sterols. All groups of one comparison are extracted and injected together, with calibration and pooled quality control injections interleaved.

5

Data processing and index computation

Peak integration is reviewed against the transitions, isomer assignments are verified against reference standards rather than accepted from library matching, concentrations are calculated against matrix-matched curves, and pathway indices are derived from the quantified inputs with the samples included in each calculation recorded.

6

Reporting and interpretation

Concentration tables, calibration and quality control documentation, index tables, pathway annotation, and methods documentation. Where a study needs group comparison, correlation with other data layers, or multivariate modeling beyond concentration tables, the analysis extends into statistical and multivariate metabolomics analysis.

Lipid metabolism analysis workflow — six-step pipeline from panel selection through pre-analytical control, extraction, acquisition, index computation, and reporting

Sample Requirements for Lipid Metabolism Analysis

Sample Type Amount Required Preparation Instructions Storage and Shipping
Serum / Plasma ≥ 50 µL Collect in EDTA or heparin tube, centrifuge promptly, aliquot the supernatant, record fasting state and hemolysis status; avoid holding at ambient temperature Store at −80°C; ship on dry ice
Tissue (liver, heart, muscle, adipose) ≥ 20 mg Snap freeze in liquid nitrogen immediately, record wet weight before freezing, keep frozen during dissection; lipid-rich tissue is processed at a lower input than other matrices Store at −80°C; ship on dry ice
Cultured Cells ≥ 1 × 106 cells Wash with cold PBS, centrifuge, remove the supernatant completely, freeze the pellet; record cell number and, where available, protein content for normalization Store at −80°C; ship on dry ice
Cell Culture Medium ≥ 200 µL Centrifuge, collect the supernatant, record the interval from medium change to collection Store at −80°C; ship on dry ice
Feces / Gut Content ≥ 50 mg Aliquot promptly and freeze the aliquot rather than the bulk material; relevant where the microbial contribution to the bile acid and short-chain pool is part of the question Store at −80°C; ship on dry ice
Urine ≥ 200 µL Centrifuge to remove debris, record the collection interval, aliquot Store at −80°C; ship on dry ice
Lipid Extract ≥ 100 µL State the extraction solvent and whether the extract has been dried; dried films are reconstituted under nitrogen rather than air Store at −80°C under inert gas where possible; ship on dry ice
Plant Material ≥ 50 mg Freeze in liquid nitrogen, grind while frozen, keep the powder at −80°C; oil-rich tissue requires a lower input Store at −80°C; ship on dry ice

Notes

  • Keep polyunsaturated lipid samples protected from light from collection onward; photo-oxidation is fast and the products overlap with the oxidized lipid mediator panel.
  • Do not add antioxidant or chelator before confirming the buffer with us. The requirement differs between the general lipid panel and the oxidized mediator workflow, and the wrong additive changes free fatty acid recovery.
  • Freeze in single-use aliquots. A second thaw changes free fatty acid and oxylipin values in a way that cannot be corrected afterwards, so record freeze-thaw history for every sample.
  • Record fasting state, collection time relative to feeding, and any lipid-lowering or dietary intervention for each sample; free fatty acids, ketone bodies, and the synthesis indices all respond to these variables.
  • Submit every group belonging to one comparison together, so that extraction order and acquisition batch cannot align with treatment group.
  • State the intended normalizer — wet weight, protein, tissue lipid content, or sample volume — at study design so it can be measured in the same extraction; a normalizer added later from a separate assay introduces a second error term.
  • Contact us before shipping samples of limited amount, such as sorted cell populations, microdialysis fractions, or small biopsies, so that extraction and the analyte list are scaled to what is available.
  • Where the same samples will also be used for oxidized lipid mediators, plan additional material; that workflow consumes a separate aliquot under different extraction conditions.

Deliverables — What You Receive

  • Quantitative concentration tables — absolute concentrations per species per sample in Excel and CSV, with free and esterified fractions in separate columns, units and matrix stated for every column, and normalizer values delivered alongside.
  • Class-level and species-level summaries — lipid class totals alongside the species that compose them, so a class change can be traced to the acyl compositions responsible rather than reported as an aggregate shift.
  • Calibration and quality control report — calibration curves with regression parameters and back-calculated accuracy, internal standard recovery per sample, pooled quality control dispersion, carryover, retention time stability, and the oxidation marker panel.
  • Pathway index tables — desaturation, elongation, synthesis versus supply, free-to-esterified, saturation balance, cholesterol source, ketone body, bile acid conjugation, and acylcarnitine pattern indices, each with its analyte inputs and the samples included.
  • Chromatographic and accurate mass data — extracted ion chromatograms for every quantified species, including the resolved isomeric pairs that were claimed, plus accurate mass spectra for species confirmed by high-resolution acquisition.
  • Pathway annotation and methods documentation — species annotated to LIPID MAPS, KEGG, and HMDB identifiers and mapped onto the routes covered by the panel, with collection, extraction, derivatization, and acquisition parameters written so that a methods section can be assembled from it.

Representative Data

Gas chromatographic separation of a fatty acid methyl ester standard mixture resolving cis and trans C18:1 isomers

Fatty acid methyl ester separation of a standard mixture, showing baseline resolution of the cis and trans C18:1 pair that shares a single mass and cannot be distinguished by mass spectrometry alone.

Matrix-matched calibration curves for free fatty acids and acylcarnitine species with isotope-labeled internal standards

Matrix-matched calibration for the free fatty acid and acylcarnitine series across the working range, with weighted regression and per-level back-calculated accuracy.

Pooled quality control dispersion of lipid classes across one acquisition batch with internal standard recovery per sample

Pooled quality control dispersion per lipid class across one acquisition batch, with internal standard recovery plotted per sample and the oxidation marker panel shown alongside.

Group comparison of lipid pools with desaturation, elongation, and synthesis indices mapped onto the metabolic routes

Group comparison of the quantified pools, with the desaturation, elongation, and synthesis-versus-supply indices mapped onto the routes they report rather than listed as isolated fold changes.

Applications of Lipid Metabolism Analysis

Hepatic Steatosis and Metabolic Disease

Separate increased storage from impaired export by reading hepatic triacylglycerol species against the free fatty acid pool and the synthesis index, instead of reporting a single liver fat value.

Cardiometabolic and Vascular Research

Relate circulating free fatty acids and their saturation profile to membrane composition and to the oxidized lipid mediators that carry the vascular risk signal.

Cancer Lipid Dependency

Test whether a tumor model depends on endogenous synthesis or on uptake, using the synthesis index, the free-to-esterified ratio, and the acyl composition of the storage pool measured together.

Mitochondrial and Rare Disease Models

Localize an oxidation defect from the acylcarnitine chain-length distribution and the ketone body ratio, which is the readout that separates an import limitation from a defect inside the oxidation spiral.

Drug Efficacy and Toxicity

Detect drug-induced phospholipidosis, steatosis, or altered desaturation before histology, by profiling the membrane and storage pools together with the same indices used for mechanism.

Nutrition, Oil Quality, and Plant Lipid Engineering

Quantify how a dietary intervention or a breeding change alters acyl composition, desaturation, and storage lipid composition in oil-rich tissue, with the composition reported species by species.

Untargeted Profiling Identifies the Lipid Classes That Accumulate When a Cardiomyocyte Lipid Droplet Route Fails


Journal: Nature Cell Biology

Published: 2023

DOI: https://doi.org/10.1038/s41556-023-01162-4


Background

Lipid droplets hold esterified lipid between rounds of use, and their handling inside cardiomyocytes sits between normal energy storage and lipotoxic injury. The study identified LIPTER, a human long non-coding RNA expressed in cardiomyocytes, as a factor required for lipid droplet transport, and had to establish what happens to the lipid pools when it is removed. Because the phenotype was expected as a redistribution among lipid classes rather than a change in total lipid mass, the analysis had to resolve the classes and their acyl compositions from limited sample amounts.

The challenge was to determine which lipid classes change when a cardiomyocyte lipid droplet route is disrupted, from a small number of differentiated cell samples, and do it with enough class resolution that the accumulating species could be assigned to the storage pool rather than to membrane lipid.


Findings (from the published study)

  • LIPTER was knocked out in human induced pluripotent stem cells and the metabolome of enriched cardiomyocytes was profiled at day 40 of differentiation, comparing knockout against wild type. The untargeted metabolomics acquisition and data analysis were performed by Creative Proteomics.
  • 10 million cardiomyocytes per sample were extracted with 800 µL of methanol together with DL-o-chlorophenylalanine and LPC (12:0) as internal standards, ultrasonicated for 30 minutes, and analyzed on an Ultimate 3000 HPLC and UHPLC coupled to Q Exactive mass spectrometry with electrospray ionization in both polarities; alignment and multivariate analysis were carried out in Compound Discover and SIMCA-P.
  • The top increased metabolites in the knockout were lipid and lipid-like molecules, including phosphatidylinositol, phosphatidic acid, and triacylglycerol. Triacylglycerol is the core lipid of a lipid droplet while phosphatidylinositol and phosphatidic acid are phospholipids of the droplet membrane, so the pattern localized the change to the droplet compartment rather than to bulk membrane lipid.
  • Lipid staining confirmed the interpretation: Oil Red O and Nile Red signal increased in the knockout and quantified droplet-positive area rose against cardiomyocyte area, while re-expression of LIPTER repressed droplet accumulation.
  • Palmitate handling was measured directly: cells were loaded with 200 µM palmitic acid for 6 hours and then depleted, with droplet density quantified separately in the whole cell and in the perinuclear and cytosolic halves.
  • The same direction appeared in vivo: mice with a cardiomyocyte-specific loss of Myh10 gained cardiac lipid on a 45 kcal% fat diet over three months, with elevated heart triacylglycerol and reduced fatty acid oxidation rates.

Heat map of the top changed metabolites in LIPTER knockout versus wild type cardiomyocytes, dominated by lipid and lipid-like molecules

Oil Red O and Nile Red lipid droplet staining with quantification of droplet-positive area against cardiomyocyte areaFigure 2. LIPTER deficiency disrupts lipid droplet balance in human induced pluripotent stem cell-derived cardiomyocytes: metabolite heat map, lipid droplet staining, and quantification of droplet-positive area against cardiomyocyte area.

Process Insight

The key result was not a fold change in one metabolite but the assignment of a class. Phosphatidylinositol and phosphatidic acid sit close enough in mass to triacylglycerol that a coarser class resolution could have reported the change as a generic increase in lipid content. Separating the classes individually is what allowed the droplet compartment to be named as the site of the defect.

Two operational decisions shaped the dataset. Sample amount was the first: differentiated cardiomyocytes yield limited material, so extraction had to be scaled to 10 million cells without losing the low-abundance species that distinguish membrane phospholipid from storage lipid. Pre-analytical control was the second: the design recorded both the palmitate loading and depletion intervals, so accumulated lipid could be attributed to transport failure rather than to a difference in fatty acid supply. The baseline measurement — often omitted — is what made the phenotype interpretable.

Where Our Lipid Metabolism Analysis Service Fits

The metabolomics in this study was performed by Creative Proteomics on the study's own samples, and the outcome depended on class-level resolution rather than on a total lipid value. The same analytical basis is available for your program:

  • Class and acyl composition resolved together — phosphatidylinositol, phosphatidic acid, and triacylglycerol quantified as separate analytes with their acyl compositions, so an accumulation can be assigned to the storage or membrane pool rather than reported as an undifferentiated lipid increase.
  • Free and esterified fractions kept apart — the same extraction reports the active free fraction against the esterified pool, the comparison that separates supply from storage in a fatty acid loading experiment.
  • Scales to limited material — the workflow tolerates small differentiated-cell samples, sorted populations, and low-volume biofluids, with the analyte list and internal standard set adjusted to the amount of material available.
  • Interpretable rather than raw output — concentrations arrive with class summaries, the pathway indices, and the pre-analytical control record, so the pathway that changed can be named in a mechanistic discussion.

Reference

  1. Han, L., Huang, D., Wu, S. et al. Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism. Nature Cell Biology 25(7), 1033–1046 (2023).

Frequently Asked Questions

How is this different from a fatty acid panel?

A fatty acid panel reports chain composition — which fatty acids are present and in what proportion. This analysis adds the esterification state, the glycerolipid and phospholipid species that carry those chains, the sterol and bile acid routes that dispose of them, and the downstream readouts for oxidation and signaling. A composition shift and a redistribution among free, storage, and membrane pools can produce identical total numbers while reflecting opposite mechanisms, so the pools are reported separately and the distribution is read directly from the values.

Do you report free fatty acids, total fatty acids, or both?

Both, as separate values, because they answer different questions. The free fraction is the metabolically available pool: it responds within minutes to lipolysis and uptake, and it is the fraction relevant to lipotoxicity, ligand availability, and insulin resistance. The esterified fraction covers triacylglycerol, cholesteryl ester, and phospholipid stores. Report only a hydrolyzed total, and a real change in the free pool disappears into the storage fraction.

Can you separate sn-1 from sn-2 acyl placement, or cis from trans isomers?

Yes, where the resolution for that pair has been established, and the report states which claims were demonstrated. Cis and trans fatty acids of equal chain length are separated by gas-phase methods after methyl ester derivatization, by retention rather than by mass. Acyl placement on the glycerol backbone requires chromatographic separation of the sn-isomers or tandem mass spectrometry against reference standards. Double-bond position requires dedicated derivatization chemistry. We confirm at design stage whether a specific pair is resolvable, and where it is not, the value is reported as combined with that limitation stated.

Can you measure flux rather than concentrations?

Not from a stored sample. Every analyte reports the size of a pool, and turnover requires a labeled precursor to have entered the system during the experiment, which has to be planned before anything is collected. The panel provides ratio-based surrogates for specific steps — desaturation, elongation, de novo lipogenesis, and the ketone body balance — which capture direction of change that a single concentration cannot, provided the dietary background and the species compared are held constant.

How are the results normalized, and why does it matter so much here?

Because lipid content varies more between samples than most metabolite classes, the normalizer can move a comparison in a different direction. We measure the intended normalizer in the same extraction — wet weight for tissue, protein for cell pellets, sample volume for biofluids, and lipid mass where the study concerns lipid content — and deliver both raw and normalized values with the basis stated for every comparison. In serum, fasting state and lipemia also have to be recorded, because a lipemic sample redistributes every analyte through lipid volume rather than through biology.

What is the smallest sample you can work with?

It depends on the matrix and the analyte list. A lipid-rich tissue such as liver or adipose supports a wide panel from a small input. A low-volume biofluid or a sorted cell population is limited both by volume and by the oxidized lipid mediators, which are present orders of magnitude below the storage lipids, so the two requirements often cannot be met from the same aliquot.

Can analytes be added to the panel?

Yes. Custom development starts with a feasibility review against our compound library and the availability of authentic standards and isotope-labeled analogues, then moves to optimization of extraction, separation, and transitions for your matrix. The method is evaluated for linearity, selectivity, and precision before study samples are analyzed, and the isomer resolution claims relevant to your analyte list are demonstrated rather than assumed. Analytes without a labeled standard can be reported as relative rather than absolute values.

What do you need along with the samples?

A sample list that matches the tube labels, giving the sample identifier, matrix, group assignment, collection time relative to feeding or dosing, fasting state, and any lipid-modifying intervention. For tissue, include the recorded wet weight; for cells, the cell number. Where a time course is involved, submit all time points from one subject together so they are extracted in a single batch. If the set has already been collected, send the storage history as well — freeze-thaw cycles, time at ambient temperature, and transit time — because it determines whether the free fatty acid and oxidized lipid data can be reported.

Sample Report

Want to See a Sample Metabolomics Report?

Review a representative report to see how sample information, analytical methods, and results are documented.

Illustrative preview of blurred metabolomics report pages with sample details, analytical methods, and results

Request a Demo Report

Complete the form below to request a sample report. Our team will follow up by email.

Select the service most relevant to your request.
For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact Us Contact Us
return-top